• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

GLP-1

Vida Health Data Shows Obesity Success Beyond GLP-1 Medications

by Syed Hamza Sohail 05/20/2025 Leave a Comment

Vida Health Data Shows Obesity Success Beyond GLP-1 Medications

What You Should Know: -   Vida Health, a virtual, personalized obesity care provider that helps patients manage obesity and related conditions, today announced outcomes from its Clinical Obesity Management Program, which demonstrate that most patients do not require expensive GLP-1s to achieve sustainable, significant weight loss. -  Data from more than 18,000 participants demonstrates that Vida’s tailored treatment plans and commitment to responsible prescribing deliver better outcomes,
Read More

PGxAI Unveils AI-Driven Genetic Tool to Personalize GLP-1 Treatment

by Jasmine Pennic 04/23/2025 Leave a Comment

PGxAI Unveils AI-Driven Genetic Tool to Personalize GLP-1 Treatment

What You Should Know:  - PGxAI, a leader in AI-powered pharmacogenomics released a new report aimed at personalizing treatment regimens for patients taking semaglutide (commonly known by brand names Ozempic and Wegovy) and other widely used weight-management drugs.  - Utilizing advanced artificial intelligence models, the report analyzes patient-specific genetic data to identify and quantify genetic variants that impact drug efficacy and safety, finding that up to a third of
Read More

Wondr Health Launches GLP-1 Support For All Benefit Plans

by Jasmine Pennic 04/22/2025 Leave a Comment

Wondr Health Launches GLP-1 Support For All Benefit Plans

What You Should Know:  - Wondr Health, a leader in digital, evidence-based lifestyle support and behavior-change interventions for weight and obesity management, has announced expansions to its comprehensive metabolic health programs.  - These expansions aim to help employers prevent and manage common and expensive weight-related chronic health conditions, while also mitigating the financial risks associated with GLP-1 coverage. GLP-1 Support for all Benefit Plans Wondr
Read More

Eli Lilly’s Oral GLP-1 Shows Positive Trial Results for Type 2 Diabetes

by Jasmine Pennic 04/17/2025 Leave a Comment

Lilly's Oral GLP-1 Shows Positive Phase 3 Results for Type 2 Diabetes

What You Should Know:  - Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes whose blood sugar was inadequately controlled through diet and exercise alone.  - Orforglipron stands out as the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3
Read More

Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response Using Precision Obesity Test

by Jasmine Pennic 04/08/2025 Leave a Comment

Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response Using Precision Obesity Test

What You Should Know:  - Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.  - The research will evaluate the MyPhenome™ test's ability to predict individual patient responses to semaglutide, a GLP-1-based therapy that has become a cornerstone in the treatment of obesity. First Prospective Clinical Study of Semaglutide Using MyPhenome™
Read More

Virta Health Cuts GLP-1 Use for Weight Loss Over 50%, Driving Cost Savings for Payers

by Jasmine Pennic 04/04/2025 Leave a Comment

Virta Health Cuts GLP-1 Use for Weight Loss Over 50%, Driving Cost Savings for Payers

What You Should Know:  - Virta Health, a leader in diabetes reversal and sustainable weight loss through its nutrition-first methodology, has announced early results from its recently launched Sustainable Weight Loss GLP-1 prescribing capabilities.  - These outcomes signal a potentially transformative shift in obesity and weight loss management, offering organizations a responsible framework for covering GLP-1 medications while actively reducing reliance and controlling overall
Read More

Collective Health, Noom Health Offer Integrated GLP-1 Weight Management Solution

by Jasmine Pennic 03/26/2025 Leave a Comment

Collective Health, Noom Health Offer Integrated GLP-1 Weight Management Solution

What You Should Know:  - Collective Health, a leader in employee health benefits, and Noom Health, the enterprise division of digital healthcare leader Noom announced a partnership to deliver Collective Health + Noom Med with SmartRx.  - The new program provides employers with an integrated weight management solution that includes a GLP-1 drug program, addressing the growing need for effective and affordable weight loss strategies. Addressing the Obesity Epidemic With
Read More

Affirm + FuturHealth Partner to Make GLP-1 Medications More Accessible with Flexible Payment Options

by Jasmine Pennic 03/25/2025 Leave a Comment

Affirm + FuturHealth Partner to Make GLP-1 Medications More Accessible with Flexible Payment Options

What You Should Know:  - FuturHealth, a provider of personalized weight-loss solutions partners with Affirm, the payment network that empowers consumers and helps merchants drive growth.  - The collaboration will enable FuturHealth customers to use Affirm's flexible, transparent pay-over-time options to purchase medications and wellness solutions. Flexible, Transparent Way to Pay Over Time for GLP-1 Medications and Wellness Solutions Now, FuturHealth customers who are
Read More

Quantum Health Launches New GLP-1 Solution for Employers

by Jasmine Pennic 03/20/2025 Leave a Comment

Quantum Health Launches New GLP-1 Solution for Employers

What You Should Know:  - Quantum Health, a provider of healthcare navigation and care coordination, has announced the expansion of its Premier Pharmacy platform to offer self-insured employers a new GLP-1 weight management solution.  - The GLP-1 offering, powered by Vida Health, aims to optimize prescribing patterns, improve clinical outcomes, and provide comprehensive member support for weight loss. Growing Demand for GLP-1 Medications The need for effective weight
Read More

PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications

by Jasmine Pennic 03/12/2025 Leave a Comment

PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications

What You Should Know:  - PatchMD, a pioneer in transdermal nutrient delivery, has unveiled its new GLP-1 Support Patch Collection, designed to provide essential support for individuals using GLP-1 receptor agonist medications such as Ozempic, Wegovy, and Mounjaro for weight management.  - GLP-1 receptor agonists have revolutionized medical weight loss, but they often come with side effects like nausea and appetite suppression, and can lead to nutrient deficiencies.  Why
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |